Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards

Digoxin offers similar performance to the bisoprolol for AF patients with heart failure

By Brian Buntz | December 24, 2020

digon molecule

Ball-and-stick model of digon molecule from Wikipedia

A randomized trial published in JAMA concluded that there was no statistically significant difference in patient-reported quality of life for atrial-fibrillation (AF) patients with heart failure symptoms who took digoxin versus the beta-blocker bisoprolol (Zebeta). 

Digoxin was once widely used for heart failure but has become less popular after a 2015 study found patients who took the drug had a higher risk of death.  

But the recent JAMA study found while digoxin and bisoprolol offered similar performance after six months of therapy, digoxin patients fared better at 12 months. Patients who received digoxin not only had fewer adverse events, they fared better in eight out of 20 secondary outcomes in the study. 

Digoxin is available as a generic and under the brand name Lanoxin from Covis Pharma. Covis acquired rights to the drug from GlaxoSmithKline  (LON: GSK) in 2011. 

Zebeta is also offered as a generic and brand-name drug from Teva Pharmaceuticals (NYSE:TEVA).

Tell Us What You Think! Cancel reply

Related Articles Read More >

Biden
Biden vows to ramp up COVID-19 vaccine distribution with $1.9T stimulus package
Amylyx
Amylyx hires new CFO 
pharmaceuticals
Unclear path for drug-pricing reform after Dem sweep 
Catalent
Catalent to acquire Acorda’s manufacturing and packaging operations 

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Pharmaceutical Processing World
  • Enews Signup
  • Contact Us
  • About Us
  • R&D World
  • DeviceTalks
  • Drug Discovery & Development
  • Drug Delivery Business News
  • MassDevice
  • Medical Design Sourcing

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards